Purchase Short-Term Access

Recombinant Human Relaxin in the Treatment of Scleroderma: A Randomized, Double-Blind, Placebo-Controlled Trial
James R. Seibold, MD; Joseph H. Korn, MD; Robert Simms, MD; Phillip J. Clements, MD, MPH; Larry W. Moreland, MD; Maureen D. Mayes, MD, MPH; Daniel E. Furst, MD; Naomi Rothfield, MD; Virginia Steen, MD; Michael Weisman, MD; David Collier, MD; Fredrick M. Wigley, MD; Peter A. Merkel, MD, MPH; Mary Ellen Csuka, MD; Vivien Hsu, MD; Susan Rocco, BS; Mark Erikson, BS; John Hannigan, MS; W. Scott Harkonen, MD; Martin E. Sanders, MD
Annals of Internal Medicine 2000;132:871-879. doi:10.7326/0003-4819-132-11-200006060-00004

Purchase Online access to this article for 24 hours
Buy Now

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.